Eribulin Ever Pharma

Eribulin Mesylate is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer. It is administered intravenously and is often considered when other treatments have not been effective. The drug targets cancer cells to inhibit their growth and spread. Patients and healthcare providers should discuss specific uses and suitability for individual cases.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some patients may experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects vary among individuals and should be monitored by a healthcare professional.

Eribulin Mesylate should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper administration procedures to avoid contamination. Patients should be aware of potential side effects and report any severe reactions to their healthcare provider immediately.

Eribulin Mesylate may interact with other medications, including those that affect liver enzymes. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also affect the drug's efficacy and should be discussed with a healthcare professional.